Nonoperative Management Protocol in Patients With Blunt Splenic Injuries

Is Strict Adherence to the Nonoperative Management Protocol Associated With Better Outcome in Patients With Blunt Splenic Injuries

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03943355

Enrollment

399

Registered

2019-05-09

Start date

2014-01-01

Completion date

2015-12-31

Last updated

2019-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blunt Injuries

Brief summary

This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period in our institution.

Detailed description

The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.

Interventions

OTHERPatient before cohort (2005-2010)

The NOM protocol with AE was recognized and accepted after our previous study reported in 2004.

OTHERPatient after cohort (2011-2016)

The protocol of NOM became more aggressively and strictly adhered to since 2011.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Adult trauma patients with blunt splenic injury who were admitted from 2005 to 2016.

Exclusion criteria

* Patients younger than 16 years * Patients who died in the emergency department

Design outcomes

Primary

Measure	Time frame	Description
The numbers of associated complications and mortality	up to 6 months	The primary outcome of interest in this study would be the associated complications and mortality.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026